A increasing attention has emerged around GLP-1 medications, particularly copyright, for their ability to address blood sugar and aid weight reduction. These novel therapies, initially developed for diabetes care, have demonstrated remarkable outcomes in supporting individuals attain their health targets. While Wegovy are connected in their mechani